.Only 4 months after Sanofi bet $80 million in ahead of time cash on Fulcrum Rehabs' losmapimod, the...
.Cancer provider Oncternal Therapeutics is actually folding all its own professional trials and also...
.Roche is holding out hopes that its own injectable weight problems prospect can ultimately demonstr...
.Novo Nordisk has lifted the lid on a phase 1 test of its dental amylin and GLP-1 receptor co-agonis...
.Simply a few brief weeks after winning an FDA Fast lane tag for its investigational BTK degrader in...
.Soon after a beneficial data decline for Eli Lilly's efsitora alfa, the Indianapolis-based company ...
.BridgeBio Pharma is actually lowering its gene treatment budget as well as pulling back coming from...
.GSK's effort to cultivate the very first injection for herpes simplex virus (HSV) has finished in f...
.GSK's long-acting asthma procedure has been actually revealed to cut in half the number of attacks ...
.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has fallen short to e...